Evidence map›Paper›PMID 28695526›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2017

Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach.

Katie Pollock, Michael Ranes, Ian Collins, Sebastian Guettler

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katie PollockDivision of Structural Biology, The Institute of Cancer Research, London, SW7 3RP, UK.
Michael RanesDivision of Structural Biology, The Institute of Cancer Research, London, SW7 3RP, UK.
Ian CollinsDivision of Cancer Therapeutics, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP, UK.
Sebastian GuettlerDivision of Structural Biology, The Institute of Cancer Research, London, SW7 3RP, UK. sebastian.guettler@icr.ac.uk.
Institute of Cancer Research · GBCancer Research UK · GB

Funding

Cancer Research UK 11566Cancer Research UK 16217Cancer Research UK C47521/A16217Wellcome TrustWellcome Trust WT102360/Z/13/Z
6 · The paper itself

Abstract

The poly(ADP-ribose)polymerase (PARP) enzyme tankyrase (TNKS/ARTD5, TNKS2/ARTD6) uses its ankyrin repeat clusters (ARCs) to recognize degenerate peptide motifs in a wide range of proteins, thereby recruiting such proteins and their complexes for scaffolding and/or poly(ADP-ribosyl)ation. Here, we provide guidance for predicting putative tankyrase-binding motifs, based on the previously delineated peptide sequence rules and existing structural information. We present a general method for the expression and purification of tankyrase ARCs from Escherichia coli and outline a fluorescence polarization assay to quantitatively assess direct ARC-TBM peptide interactions. We provide a basic protocol for evaluating binding and poly(ADP-ribosyl)ation of full-length candidate interacting proteins by full-length tankyrase in mammalian cells.

Indexed as

AnimalsBinding SitesHumansPoly ADP RibosylationProtein BindingTankyrasesTelomereTankyrasesEnzyme–substrate relationshipsFluorescence polarization (FP)PARPPoly(ADP-ribosyl)ationProtein expressionProtein-protein interactionsProtein purificationStructural biologyTankyraseTankyrase-binding peptide motif

Identifiers

PMID28695526
PMCPMC6082341
OpenAlexW2735019350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.